Proteus mirabilis

Proteus mirabilis is a common gram-negative bacterium that lives in soil, water, and the intestines of humans and animals, where it usually causes no trouble at all. Its reputation, and the reason it matters to doctors, comes from what it does when it reaches the urinary tract. There it becomes one of the leading causes of complicated and catheter-associated urinary tract infections (UTIs) — and, uniquely, it can drive the formation of large kidney and bladder stones made of a mineral called struvite. It does this with an enzyme called urease, which turns urine alkaline and quite literally builds stones around the bacteria that shelter inside them. This page explains what Proteus is (including its famous "swarming" behavior and telltale ammonia smell), why the urease-and-stone story is the key to understanding it, who is most at risk, and how it is diagnosed, treated, and prevented. The tone here is honest and practical: Proteus is rarely a threat to a healthy person with a normal urinary tract, but for people with catheters, spinal-cord injuries, or structural problems it is a serious and stubborn opponent.

Table of Contents

  1. Overview
  2. The Bacterium: Swarming and the Ammonia Smell
  3. Urinary Tract Infections — The Flagship
  4. Urease and Struvite Stones
  5. Other Infections
  6. Who Is Most at Risk
  7. Diagnosis
  8. Treatment
  9. Prevention
  10. The Honest Bottom Line
  11. Research Papers
  12. Connections
  13. Featured Videos

Overview

Proteus mirabilis is a rod-shaped, gram-negative bacterium in the family Morganellaceae (long grouped with the Enterobacteriaceae, the same broad family as E. coli and Klebsiella). It is a normal, harmless resident of the gut in many people and animals, and it is widespread in the environment — in soil, sewage, and water. In that setting it is simply part of the microbial background.

The bacterium was named after Proteus, the shape-shifting sea-god of Greek myth, because of the way it changes form and spreads restlessly across a laboratory plate. That name turns out to fit its clinical behavior too. When Proteus gets into the urinary tract — usually via a catheter, an anatomical abnormality, or after repeated infections — it can transform from a harmless gut organism into a persistent, stone-building pathogen.

The single most important thing to understand about Proteus mirabilis is its enzyme urease. Almost everything that makes this organism clinically dangerous — alkaline urine, struvite stones, blocked catheters, recurrent infection — flows from that one enzyme. Keep urease in mind as you read; it is the thread that ties the whole page together.

The Bacterium: Swarming and the Ammonia Smell

Proteus mirabilis has two laboratory features so distinctive that microbiologists often recognize it before any formal test is run.

Swarming motility

The first is swarming. On most agar plates, a bacterial colony sits as a compact dot where it was placed. Proteus does not. When conditions are right, its cells undergo a dramatic change: individual short rods elongate into long, snake-like "swarmer cells" studded with hundreds of extra flagella (the whip-like tails bacteria use to move). These swarmer cells move together in coordinated waves, migrating outward across the plate. Then they pause, revert to normal short cells, multiply, and swarm again. The result is a series of visible concentric rings — a bull's-eye pattern — spreading across the surface of the agar. To the naked eye it looks as if the bacteria have covered the entire plate in a thin, rippling film.

This is not just a party trick. Swarming reflects the same machinery Proteus uses to move along the surface of a urinary catheter and up the urinary tract, and the swarmer state is linked to the production of urease and other factors that damage tissue. Swarming can also make the laboratory's job harder, because the film can spread over and obscure other bacteria on the same plate.

The fishy, ammonia smell

The second feature is smell. A Proteus culture — and often the urine of a person heavily infected with it — has a characteristic strong, fishy, ammonia-like odor. That smell is a direct clue to the urease enzyme at work: urease breaks down urea into ammonia, and ammonia is what you are smelling. A distinctly ammoniacal, "off" smell to the urine, especially in someone with a long-term catheter, is a real-world hint that a urease-producing organism like Proteus may be present.

Beyond these two signatures, Proteus mirabilis is urease-positive, produces hydrogen sulfide gas (which blackens certain test media), and — importantly for telling it apart from its cousin Proteus vulgaris — is typically indole-negative. These simple biochemical fingerprints, together with the swarming, let a lab identify it quickly and cheaply.

Urinary Tract Infections — The Flagship

The urinary tract is where Proteus mirabilis earns its clinical reputation. In healthy young women with ordinary, uncomplicated bladder infections, E. coli is by far the dominant cause and Proteus is relatively uncommon. But the picture flips in complicated urinary infections — infections in a urinary tract that is not normal, whether because of a catheter, an obstruction, a stone, a neurological problem, or repeated prior infections. In that population, Proteus mirabilis is one of the most important pathogens.

Two settings stand out:

A Proteus UTI can range from a mild, barely-noticed bacteriuria (bacteria in the urine) to painful cystitis, to a serious kidney infection (pyelonephritis), to bloodstream infection. What makes it different from a routine E. coli bladder infection is what it can build while it is there: stones. That is the subject of the next section, and it is the genuinely important part of the Proteus story.

Urease and Struvite Stones

This is the heart of the matter. If you remember one thing about Proteus mirabilis, make it this.

What urease does

Proteus produces large amounts of an enzyme called urease. Urease splits urea — a normal waste product dissolved in everyone's urine — into ammonia and carbon dioxide. The ammonia is a base, so as urease works, it drives the urine's pH up: normal urine is mildly acidic, but in a Proteus infection it becomes alkaline (pH well above 7).

Here is why that matters. Certain minerals dissolved in urine stay dissolved only when the urine is acidic. Turn the urine alkaline, and those minerals fall out of solution as solid crystals — the same way sugar will crystallize out of a syrup as conditions change. The two minerals that precipitate are magnesium ammonium phosphate (struvite) and carbonate apatite (a calcium phosphate). These crystals clump and grow into struvite stones.

"Infection stones" and staghorn calculi

Struvite stones are also called "infection stones," because — unlike the common calcium-oxalate kidney stones that form for metabolic reasons — they form only in the presence of urease-producing bacteria. They are essentially built by the bacteria. And they can grow alarmingly fast, sometimes filling the entire branching collecting system of the kidney to form a large, antler-shaped stone called a staghorn calculus. Struvite is the classic cause of these big staghorn stones.

The self-perpetuating cycle

Now the crucial, practical insight: the stone and the infection protect each other. The growing stone traps Proteus bacteria deep inside its layers, where antibiotics and the body's immune defenses cannot easily reach them. Sheltered there, the bacteria keep producing urease, keep the urine alkaline, and keep the stone growing. It becomes a vicious circle: the infection builds the stone, and the stone shelters the infection. This is why a Proteus stone infection is so hard to cure with antibiotics alone — as long as the stone remains, there is a permanent reservoir of bacteria that the drugs cannot fully clear.

Catheter encrustation

The same chemistry wrecks catheters. On an indwelling catheter, Proteus urease raises the local pH and lays down struvite and apatite crystals directly on and inside the tube. Over days to weeks this encrustation can narrow and completely block the catheter, causing urine to back up — a common, miserable, and recurring problem for people who rely on long-term catheters. Recognizing that Proteus is behind repeated catheter blockages is often the first step to managing them.

Other Infections

Although the urinary tract is its main stage, Proteus mirabilis can cause infection elsewhere, almost always in people who are already vulnerable:

In nearly every case, the theme is the same: Proteus is an opportunist. It takes advantage of catheters, broken skin, obstruction, or weakened immunity rather than attacking healthy, intact tissue.

Who Is Most at Risk

Proteus mirabilis infection is strongly tied to specific risk factors. The people most likely to develop a significant Proteus infection are those with:

By contrast, a healthy adult with a normal urinary tract and no catheter is at low risk of serious Proteus disease. This is fundamentally an infection of vulnerable urinary tracts, not healthy ones.

Diagnosis

Diagnosing a Proteus infection combines the laboratory and, when stones are suspected, imaging.

Urine testing

Imaging for stones

Because Proteus so often goes hand-in-hand with struvite stones, imaging is important whenever infection is severe, recurrent, or slow to clear. A CT scan is the most sensitive way to find and map stones; ultrasound and a plain abdominal X-ray (KUB) are also used. Finding a staghorn or other stone changes the whole treatment plan, because the stone will need to be dealt with directly — not just the infection.

Treatment

Treating Proteus mirabilis rests on two principles: use the right antibiotic, and remove the stone.

Antibiotics — guided by susceptibility

Antibiotic choice must be guided by the culture's susceptibility results, because Proteus has some important quirks:

Removing the stone — the key to cure

Here is the point that surprises many people: when a struvite (infection) stone is present, antibiotics alone usually cannot cure the infection. As long as the stone remains, it shelters live bacteria that antibiotics cannot reach, and the infection returns again and again. The definitive cure is to remove the stone completely, most often with a minimally invasive surgical procedure (percutaneous nephrolithotomy is the standard approach for large staghorn stones), so that no bacteria-harboring fragments are left behind. Antibiotics are given around the procedure and afterward, but the surgery is what breaks the cycle. Incomplete stone removal — leaving even small fragments — commonly leads to regrowth and reinfection.

In selected cases where surgery is not possible, a urease-inhibiting drug (acetohydroxamic acid) can slow stone growth, but it has meaningful side effects and is not a substitute for removing the stone. Blocked or encrusted catheters generally need to be changed, not just flushed.

Prevention

Because Proteus exploits catheters, stones, and stagnant urine, prevention targets exactly those things:

Importantly, not every finding of Proteus in the urine needs antibiotics. Asymptomatic bacteriuria — bacteria present without any symptoms — is usually best left untreated in most people, because treating it does not help and drives resistance. The main exceptions are pregnancy and before certain urological procedures.

The Honest Bottom Line

Proteus mirabilis is a common, ordinarily harmless bacterium that becomes a serious problem in a specific situation: a urinary tract that is not normal — catheterized, obstructed, neurologically impaired, or stone-bearing. For a healthy person with a normal urinary tract, it is rarely a threat, and finding it in the urine without symptoms usually needs no treatment.

Where it does cause disease, its defining feature is the enzyme urease: by turning urine alkaline, it builds struvite "infection stones" and encrusts catheters, and those stones in turn shelter the bacteria in a self-perpetuating cycle. The single most important practical lesson follows directly from that: you generally cannot cure a Proteus stone infection with antibiotics alone — the stone must come out. Add to this its intrinsic resistance to nitrofurantoin and tetracyclines (so those drugs must not be relied upon) and its capacity for broader resistance, and the message is clear. The best outcomes come from prevention — minimizing catheter use, staying well hydrated, and treating stones and obstruction — and, when infection with stones does occur, from combining susceptibility-guided antibiotics with definitive removal of the stone. None of this requires panic; it requires the right diagnosis and the right plan.

Research Papers

  1. Schaffer JN, Pearson MM. Proteus mirabilis and Urinary Tract Infections. Microbiology Spectrum. 2015;3(5). doi:10.1128/microbiolspec.UTI-0017-2013 — The definitive modern review of how Proteus colonizes the urinary tract, produces urease, and builds stones.
  2. Coker C, Poore CA, Li X, Mobley HL. Pathogenesis of Proteus mirabilis urinary tract infection. Microbes and Infection. 2000;2(12):1497–1505. doi:10.1016/s1286-4579(00)01304-6 — A foundational review of the virulence factors (urease, fimbriae, flagella) that drive Proteus disease.
  3. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews. 2008;21(1):26–59. doi:10.1128/CMR.00019-07 — Comprehensive review of catheter-associated UTI, crystalline biofilms, and catheter encrustation.
  4. Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis Infection. EcoSal Plus. 2018;8(1). doi:10.1128/ecosalplus.ESP-0009-2017 — An up-to-date synthesis of Proteus biology, from swarming to stone formation to bloodstream infection.
  5. Schaffer JN, Norsworthy AN, Sun TT, Pearson MM. Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation. Proceedings of the National Academy of Sciences. 2016;113(16):4494–4499. doi:10.1073/pnas.1601720113 — Shows in detail how urease-producing bacterial clusters seed the growth of bladder stones.
  6. Norsworthy AN, Pearson MM. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis. Trends in Microbiology. 2017;25(4):304–315. doi:10.1016/j.tim.2016.11.015 — Traces the full arc of Proteus infection from catheter colonization to stone disease.
  7. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nature Clinical Practice Urology. 2008;5(11):598–608. doi:10.1038/ncpuro1231 — Explains how urease-driven crystalline biofilms block catheters and why Proteus is central to the problem.
  8. Chen CY, Chen YH, Lu PL, Lin WR, Chen TC, Lin CY. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. Journal of Microbiology, Immunology and Infection. 2012;45(3):228–236. doi:10.1016/j.jmii.2011.11.007 — Clinical study confirming that Proteus bloodstream infection most often arises from a urinary source.
  9. Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. Urinary infection stones. International Journal of Antimicrobial Agents. 2002;19(6):488–498. doi:10.1016/s0924-8579(02)00088-2 — Reviews how urease-splitting bacteria create struvite (infection) stones and why the stones must be removed.
  10. O'Hara CM, Brenner FW, Miller JM. Classification, Identification, and Clinical Significance of Proteus, Providencia, and Morganella. Clinical Microbiology Reviews. 2000;13(4):534–546. doi:10.1128/CMR.13.4.534 — Reference guide to the laboratory features (including swarming and indole reaction) used to identify Proteus.
  11. Armbruster CE, Mobley HLT. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nature Reviews Microbiology. 2012;10(11):743–754. doi:10.1038/nrmicro2890 — A readable review connecting the organism's famous swarming behavior to its role as a pathogen.
  12. Mobley HL, Belas R. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends in Microbiology. 1995;3(7):280–284. doi:10.1016/s0966-842x(00)88945-3 — Classic paper linking the swarmer-cell state to urease production and urinary-tract virulence.

Back to Table of Contents

Connections

Back to Table of Contents